Factors associated with willingness to take extended release naltrexone among injection drug users

BACKGROUND: Although opioid-agonist therapy with methadone or buprenorphine/naloxone is currently the mainstay of medical treatment for opioid use disorder, these medications often are not well accepted or tolerated by patients. Recently, extended release naltrexone (XR-NTX), an opioid antagonist, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahamad, Keith, Milloy, MJ, Nguyen, Paul, Uhlmann, Sasha, Johnson, Cheyenne, Korthuis, Todd P, Kerr, Thomas, Wood, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636793/
https://www.ncbi.nlm.nih.gov/pubmed/25935714
http://dx.doi.org/10.1186/s13722-015-0034-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636793/
https://www.ncbi.nlm.nih.gov/pubmed/25935714
http://dx.doi.org/10.1186/s13722-015-0034-5

Ejemplares similares